The C1QTNF family, short for C1q and TNF related proteins, consists of a group of secreted proteins that are characterized by a C1q domain at their C-terminus, similar to that found in the complement component C1q and tumor necrosis factor (TNF). These proteins are involved in various biological processes, including inflammation, metabolism, and cell signaling. The C1QTNF family members are known to interact with a range of receptors and signaling molecules, influencing pathways related to insulin sensitivity, adipocyte function, and energy homeostasis. Functionally, C1QTNF proteins have been implicated in the regulation of glucose and lipid metabolism, and disturbances in their expression or activity are associated with metabolic disorders such as obesity, diabetes, and cardiovascular diseases.
Some members of this family are also involved in modulating immune responses, potentially influencing the development and progression of inflammatory and autoimmune diseases. The signaling pathways activated by C1QTNF proteins can involve classical receptors, such as G protein-coupled receptors, and can lead to the activation of various downstream signaling cascades, including NF-κB and MAPK pathways. Targeting C1QTNF proteins for disruption or inhibition using small molecules allows for the exploration of their role in metabolic and inflammatory pathways. By inhibiting the activity of these proteins, researchers can observe changes in metabolic processes, such as glucose and lipid metabolism, and assess the impact on related diseases like diabetes and obesity. Small molecule inhibitors can also help elucidate the role of C1QTNF proteins in immune modulation, providing insights into their involvement in inflammation and autoimmune conditions.
Items 1 to 10 of 20 total
画面:
製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPKを阻害し、細胞ストレス応答におけるC1QTNF(C1qとTNF関連)の役割に影響を与える。 | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
CaMKIIを阻害し、カルシウムシグナル伝達経路のC1QTNF(C1qとTNF関連)に影響を及ぼす可能性がある。 | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
カルシウム依存性経路におけるC1QTNF(C1qおよびTNF関連)の機能を阻害することができるカルシウムキレート剤。 | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
JNK阻害剤は、C1QTNF(C1qとTNF関連)の細胞ストレスと生存における役割に影響を与えることができる。 | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $204.00 $265.00 | 29 | |
Aktを阻害し、細胞の生存と増殖に関連する経路のC1QTNF(C1qとTNF関連)シグナル伝達に影響を与える。 | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
C1QTNF(C1qおよびTNF関連)とリン酸化を必要とする酵素との相互作用を阻害することができるゲニステインキナーゼ阻害剤。 | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
ルキソリチニブはJAK1およびJAK2阻害剤であり、JAK-STAT経路を破壊し、C1QTNF(C1qおよびTNF関連)の産生および炎症反応のダウンレギュレーションをもたらす。 | ||||||
Baricitinib | 1187594-09-7 | sc-364730 sc-364730A | 5 mg 25 mg | $196.00 $651.00 | ||
バリシチニブは、JAK1およびJAK2を標的としてC1QTNF(C1qおよびTNF関連)を阻害し、炎症およびサイトカイン放出に関与する細胞内シグナル伝達経路を破壊する。 | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $52.00 $86.00 | 6 | |
イブプロフェンは、アラキドン酸から炎症性プロスタグランジンへの変換を担うCOX酵素を阻害することにより、C1QTNF(C1qおよびTNF関連)レベルを低下させる。 | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
メトトレキサートはジヒドロ葉酸還元酵素(DHFR)を阻害し、免疫反応に関与する細胞におけるDNA合成とC1QTNF(C1qおよびTNF関連)の産生を抑制する。 |